Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder: A Phase 2 Randomized Controlled Trial

NCT06021431 is registered in ClinicalTrials.gov with BehaVR LLC as lead sponsor.

NCT NCT06021431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder: A Phase 2 Randomized Controlled Trial
Lead sponsor
BehaVR LLC
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 7, 2023
Completion date
September 30, 2025
Enrollment
128 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder